Roche NimbleGen Unveils Pre-capture Multiplexing

November 2011
Worldwide Biotech;Nov2011, Vol. 23 Issue 11, p1
Trade Publication
A preview of the pre-capture multiplex target enrichment protocol and the NimbleGen SeqCap EZ Exome Library v3.0, both from Roche NimbleGen is presented.


Related Articles

  • Targeted Genome Resequencing.  // Drug Discovery & Development;Jul2008, Vol. 11 Issue 7, p23 

    The article evaluates Roche NimbleGen's Sequence Capture technology for selecting targeted regions of the genome for high throughput sequencing.

  • Deals roundup.  // Diagnostics & Imaging Week;3/20/2008, Vol. 11 Issue 12, p2 

    The article reports on the decision of Roche NimbleGen and Affymetrix to expand the license to a number of Affymetrix patents that were originally granted in October 2006. The expanded license will provide certain diagnostic rights to array-based DNA copy number analysis and array-based...

  • H1N1 can be tracked by new method from Singapore.  // Medical Device Daily;8/10/2009, Vol. 13 Issue 152, p7 

    The article reports on the development of a novel approach by scientists at Genome Institute of Singapore led by Chief Scientific Officer Christopher Wong designed to reveal the complete sequence of any influenza A virus using a nasal swab or nasal pharyngeal wash from patients. The said...

  • Agreements/contracts.  // Medical Device Daily;10/21/2009, Vol. 13 Issue 203, p4 

    The article discusses the supply agreement between Roche NimbleGen in Madison, Wisconsin and quantitative nuclease protection assay (qNPA) provider High Throughput Genomics (HTG) in Tucson, Arizona. Stipulated in the agreement is that Roche NimbleGen will be providing HTG with high density and...

  • Deals roundup.  // Medical Device Daily;3/14/2008, Vol. 12 Issue 51, p4 

    This article focuses on the expanded license agreement signed between Roche NimbleGen and Affymetrix. Certain diagnostic rights for array-based deoxyribonucleic acid (DNA) copy number analysis are included in the expanded license, as well as array-based resequencing. Particular focus is given to...

  • Agreements.  // Medical Device Daily;6/5/2008, Vol. 12 Issue 108, p4 

    The article focuses on a strategic alliance by Basel, Switzerland-based Roche NimbleGen with BioDiscovery of Los Angeles, California to offer solutions to comparative genomic hybridization (CGH) microarray customers. As part of this partnership, the two companies will co-market and co-promote...

  • Agreements/contracts.  // Medical Device Daily;11/17/2010, Vol. 14 Issue 224, p3 

    The article reports that Canterbury Health Laboratories is using the NimbleGen CGX Cytogenetics Microarray Solution from Roche NimbleGen.

  • Agreements/contracts.  // Medical Device Daily;7/6/2009, Vol. 13 Issue 127, p4 

    The article reports on the partnership of Roche NimbleGen and Korea Centers for Disease Control and Prevention and Macrogen in 2009. The entities aim to work on an eight-month intensive copy number variation (CNV) study of Korean individuals. The study is expected to contain large-scale...

  • BaseClear BV Certified to Provide NimbleGen Sequence Capture Services in the Netherlands.  // Biomedical Market Newsletter;5/28/2011, p681 

    The article reports on the participation of the Netherlands-based genomic service provider BaseClear BV on Roche NimbleGen Inc.'s Certified Service Provider (CSP) Program. Bas Reichert, commercial director of BaseClear, expresses his pleasure for being the first Roche NimbleGen Certified Service...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics